Table 2 General characteristics of study patients
Variables | Saffron group (N:45) | Placebo group (N:45) | P-value* |
|---|---|---|---|
Age, years | 54.33 ± 2.2 | 54.17 ± 2.48 | 0.96 |
Female, n (%) | 17 (37.8%) | 18 (40%) | 0.82 |
Weight (Kg) | 76.80 ± 1.33 | 73.56 ± 1.35 | 0.09 |
Calf circumference (cm) | 33.37 ± 0.49 | 32.12 ± 0.0.47 | 0.07 |
MAC (cm) | 29.29 ± 0.90 | 27.31 ± 0.44 | 0.05 |
Reason for ICU admission | 0.23 | ||
Medical | 8 (17.8%) | 8 (17.8%) | |
Trauma | 32 (71.7%) | 26 (57.8%) | |
Surgical | 5 (11.1%) | 11 (24.4%) | |
Energy requirement (Cal) | 18,028 ± 20.55 | 1800.3526 ± 27.18 | 0.40 |
Energy intake (Cal) | 1807.84 ± 17.48 | 1785.98 ± 165.78 | 0.47 |
Source of sepsis | 0.41 | ||
Pulmonary infection | 35 (77.8%) | 28 (62.2%) | |
Abdominal infection | 3 (6.7%) | 5 (11.1) | |
CSF infection | 1 (2.2%) | 3 (6.7%) | |
Bacteremia | 6 (13.3%) | 9 (20%) | |
MAP (mmHg) | 92.86 ± 1.87 | 89.68 ± 1.72 | 0.21 |
Current medication | |||
NSAID | 40 (88.9%) | 37 (82.2%) | 0.36 |
Insulin | 4 (8.9%) | 6 (13.3%) | 0.50 |
PPI | 40 (88.9%) | 42 (93.3%) | 0.45 |
Anticoagulant | 42 (93.3%) | 38 (84.4%) | 0.18 |
Current supplement | |||
Zinc | 34 (75.6%) | 37 (82.2%) | 0.43 |
Vitamin C | 6 (13.3%) | 3 (6.7%) | 0.48 |
Vitamin B1 | 27 (60%) | 25 (55.6%) | 0.67 |
Vitamin D | 32 (71.1%) | 35 (77.8%) | 0.46 |
Magnesium | 6 (13.3%) | 12 (26.7%) | 0.11 |
Vitamin B-complex | 2 (4.4%) | 4 (8.9%) | 0.67 |